MarketsHealth Tech
$HIMS
Hims & Hers
Stories that name Hims & Hers, newest first.
News, not investment advice.
- Breakthroughs71%Some rectal cancer patients can now skip surgery, chemo and radiation after FDA approves Jemperli
- Wearables22 to 50What the FDA has actually cleared in cuffless blood pressure
- Digital HealthFDA will treat most apps that come with prescription drugs like ads, unless the drugmaker proves they help
- Healthcare & Insurance95%Humana says 95% of its Medicare Advantage members are in 4-star plans for 2027, up from 20%
- Healthcare & Insurance17 to 4CMS plan would stop Medicare paying for outsourced remote monitoring
- Healthcare & Insurance71%AEP 2027 scorecard: more members in 4-star plans, fewer counties for some big insurers
- Employer Benefits & ACAOscar grows its county count 24% as ACA insurers set 2027 plans
- Digital Health$149How drugmakers and wearables are reaching patients directly
- AI in CareDoximity adds UpToDate to its AI tool, days after its OpenEvidence lawsuit ended
- Breakthroughs24%FDA approves Hibsago, a hepatitis B drug that lets some patients stop treatment
- Healthcare & InsuranceJudi Health gets a CMS contract for its own employer retiree Part D plan
- WearablesOura adds Cardio Effort and automatic VO2 max to its ring
NovoCare (Novo Nordisk)